UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 122

Sortiert nach

Biomarker dynamics and prognosis in breast cancer after neoadjuvant chemotherapy

Scientific reports, 2022-01, Vol.12 (1), p.91-91, Article 91

2022

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy Before Liver Resection of Colorectal Metastases: Friend or Foe?

Annals of surgery, 2012-02, Vol.255 (2), p.237-247

2012

Link zum Volltext

Verfügbarkeit prüfen

Treatment of breast cancer brain metastases

European journal of pharmacology, 2013-10, Vol.717 (1-3), p.84-87

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase Ib dose-escalation study of the hypoxia-modifier Myo-inositol trispyrophosphate in patients with hepatopancreatobiliary tumors

Nature communications, 2021-06, Vol.12 (1), p.1-12, Article 3807

2021

Link zum Volltext

Verfügbarkeit prüfen

Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials

Journal of clinical oncology, 2008-06, Vol.26 (18), p.3006-3014

2008

Link zum Volltext

Verfügbarkeit prüfen

Cediranib Plus FOLFOX/CAPOX Versus Placebo Plus FOLFOX/CAPOX in Patients With Previously Untreated Metastatic Colorectal Cancer: A Randomized, Double-Blind, Phase III Study (HORIZON II)

Journal of clinical oncology, 2012-10, Vol.30 (29), p.3596-3603

2012

Link zum Volltext

Verfügbarkeit prüfen

Prospective Phase II Trial of Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Resectable Adenocarcinoma of the Pancreatic Head

Journal of clinical oncology, 2008-05, Vol.26 (15), p.2526-2531

2008

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant chemotherapy generates a significant tumor response in resectable pancreatic cancer without increasing morbidity: results of a prospective phase II trial

Annals of surgery, 2008-12, Vol.248 (6), p.1014-1022

2008

Link zum Volltext

Verfügbarkeit prüfen

Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness

Annals of surgery, 2005-08, Vol.242 (2), p.235-243

2005

Link zum Volltext

Verfügbarkeit prüfen

Effects of dignity therapy on psychological distress and wellbeing of palliative care patients and family caregivers - a randomized controlled study

BMC palliative care, 2024-03, Vol.23 (1), p.73-73

2024

Link zum Volltext

Verfügbarkeit prüfen

Treatment strategies and outcome of surgery for synchronous colorectal liver metastases

Swiss medical weekly, 2017-08, Vol.147, p.w14486

2017

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)

BMC cancer, 2011-08, Vol.11 (1), p.346-346, Article 346

2011

Link zum Volltext

Verfügbarkeit prüfen

Using the EuroQol EQ-5D in Swiss Cancer Patients, Which Value Set Should be Applied?

PharmacoEconomics, 2014-06, Vol.32 (6), p.591-599

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of Docetaxel on blood-brain barrier function and formation of breast cancer brain metastases

Journal of experimental & clinical cancer research, 2019-10, Vol.38 (1), p.434-434, Article 434

2019

Link zum Volltext

Verfügbarkeit prüfen

Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas

Hepatology (Baltimore, Md.), 2009-05, Vol.49 (5), p.1602-1609

2009

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study

BMC cancer, 2018-01, Vol.18 (1), p.72-72, Article 72

2018

Link zum Volltext

Verfügbarkeit prüfen

IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas

Human pathology, 2009-10, Vol.40 (10), p.1377-1383

2009

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10)

BMC cancer, 2017-04, Vol.17 (1), p.265-265, Article 265

2017

Link zum Volltext

Verfügbarkeit prüfen

Exploring prognostic factors for HER2-positive metastatic breast cancer: a retrospective cohort study in a major Swiss hospital

Swiss medical weekly, 2016-12, Vol.146, p.w14393

2016

Link zum Volltext

Verfügbarkeit prüfen

Limits of simplicity

Journal of clinical oncology, 2010-08, Vol.28 (23), p.e407-e407

Pestalozzi, Bernhard C

2010

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: An economic evaluation

European journal of cancer (1990), 2009-05, Vol.45 (8), p.1397-1406

2009

Link zum Volltext

Verfügbarkeit prüfen

Delivery of health care at the end of life in cancer patients of four swiss cantons: a retrospective database study (SAKK 89/09)

BMC cancer, 2014-05, Vol.14 (1), p.306-306, Article 306

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 122

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(112)

Publikationsform

Sprache

Englisch
(112)
Deutsch
(9)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(86)
Humans
(85)
Life Sciences & Biomedicine
(84)
Female
(58)
Oncology
(58)
Middle Aged
(49)
Aged
(39)
Male
(39)
Biological And Medical Sciences
(37)
Medical Sciences
(36)
Adult
(35)
Tumors
(34)
Chemotherapy
(27)
Treatment Outcome
(22)
Breast Cancer
(20)
Breast Neoplasms - Pathology
(17)
Prognosis
(17)
Aged, 80 And Over
(16)
Breast Neoplasms - Drug Therapy
(15)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Biomarker dynamics and prognosis in breast cancer after neoadjuvant chemotherapy

Chemotherapy Before Liver Resection of Colorectal Metastases: Friend or Foe?

Treatment of breast cancer brain metastases

CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01)

Phase Ib dose-escalation study of the hypoxia-modifier Myo-inositol trispyrophosphate in patients with hepatopancreatobiliary tumors

Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials

Cediranib Plus FOLFOX/CAPOX Versus Placebo Plus FOLFOX/CAPOX in Patients With Previously Untreated Metastatic Colorectal Cancer: A Randomized, Double-Blind, Phase III Study (HORIZON II)

Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group

Prospective Phase II Trial of Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Resectable Adenocarcinoma of the Pancreatic Head

Neoadjuvant chemotherapy generates a significant tumor response in resectable pancreatic cancer without increasing morbidity: results of a prospective phase II trial

Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness

Effects of dignity therapy on psychological distress and wellbeing of palliative care patients and family caregivers - a randomized controlled study

Treatment strategies and outcome of surgery for synchronous colorectal liver metastases

Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)

Using the EuroQol EQ-5D in Swiss Cancer Patients, Which Value Set Should be Applied?

Impact of Docetaxel on blood-brain barrier function and formation of breast cancer brain metastases

Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas

Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study

Clinical Benefit and Quality of Life in Patients With Advanced Pancreatic Cancer Receiving Gemcitabine Plus Capecitabine Versus Gemcitabine Alone: A Randomized Multicenter Phase III Clinical Trial—SAKK 44/00–CECOG/PAN.1.3.001

IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas

Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10)

Exploring prognostic factors for HER2-positive metastatic breast cancer: a retrospective cohort study in a major Swiss hospital

Limits of simplicity

Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: An economic evaluation

Delivery of health care at the end of life in cancer patients of four swiss cantons: a retrospective database study (SAKK 89/09)

Suchergebnisse filtern